Esperion Therapeutics | ESPR - Zapasy





Zapasy Zmiana Data
AbbVie USD 4.95B 13M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
Amgen USD 6.22B 121M 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Cipla INR 61.6B 5.18B 2025-09
CSL USD 6.47B 327M 2025-06
Cytokinetics USD 0 0 2023-12
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Geron USD 116.64M 21.21M 2025-12
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
United Therapeutics USD 183.1M 6.6M 2025-12
Vanda Pharmaceuticals USD 1.85M 190K 2025-12